Detail akcie CUPR Rg-A online

Business Summary: Cuprina Holdings (Cayman) Limited is a biomedical and biotechnology company, which is engaged in the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. Its segments include Maggot Debridement Therapy Product (MDT) and Cosmeceutical Product. It manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as MDT, which is an effective alternative to surgical debridement. It has two lines of chronic wound care products in its pipeline, such as Collagen dressings, including sponges, particles and hydrogels utilizing bullfrog collagen derived from the valorization of abattoir waste streams of American bullfrogs (Lithobates catesbeianus) and products utilizing medical leeches for wound treatment.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Cuprina Holdings (Cayman) Ltd revenues decreased 44% to SP$23K. Net loss increased from SP$704K to SP$2M. Revenues reflect Cosmeceutical Product segment decrease from SP$17K to SP$0K, Maggot Debridement Therapy Product segment decrease of 5% to SP$23K. Higher net loss reflects Other operating expenses - Bal increase from SP$286K to SP$1.4M (expense), Other income decrease of 69% to SP$47K (income).